A detailed history of Two Sigma Securities, LLC transactions in Lexicon Pharmaceuticals, Inc. stock. As of the latest transaction made, Two Sigma Securities, LLC holds 24,527 shares of LXRX stock, worth $17,414. This represents 0.0% of its overall portfolio holdings.

Number of Shares
24,527
Previous 17,771 38.02%
Holding current value
$17,414
Previous $29,000 31.03%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$1.51 - $2.39 $10,201 - $16,146
6,756 Added 38.02%
24,527 $38,000
Q2 2024

Aug 14, 2024

BUY
$1.54 - $2.28 $27,367 - $40,517
17,771 New
17,771 $29,000
Q4 2023

Feb 14, 2024

BUY
$1.0 - $1.53 $38,268 - $58,550
38,268 New
38,268 $58,000
Q1 2021

May 17, 2021

SELL
$3.45 - $9.09 $69,010 - $181,827
-20,003 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$1.05 - $3.67 $21,003 - $73,411
20,003 New
20,003 $68,000

Others Institutions Holding LXRX

About LEXICON PHARMACEUTICALS, INC.


  • Ticker LXRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 188,726,000
  • Market Cap $134M
  • Description
  • Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...
More about LXRX
Track This Portfolio

Track Two Sigma Securities, LLC Portfolio

Follow Two Sigma Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Securities, LLC with notifications on news.